維持性血液透析患者感染新型冠狀病毒后并發免疫性血小板減少一例_West China Medical Journal

Authors：

任文 ¹ , 王燕 ¹ , 沈玉婷 ^1,2 , 付平 ¹ , 李玲 ¹ ,  鄭蘭 ^1,3

1. ;
2. ;
3. ;

Corresponding?author：

鄭蘭, Email: 1187616487@qq.com

Keywords：

血液透析; 新型冠狀病毒; 免疫性血小板減少

DOI：

10.7507/1002-0179.202306133

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 任文, 王燕, 沈玉婷, 付平, 李玲, 鄭蘭. 維持性血液透析患者感染新型冠狀病毒后并發免疫性血小板減少一例. West China Medical Journal, 2024, 39(7): 1168-1170. doi: 10.7507/1002-0179.202306133 Copy

1.	Tumaini Massaro J, Chen Y, Ke Z. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis. Platelets, 2019, 30(7): 828-835.
2.	Kostic M, Zivkovic N, Cvetanovic A, et al. CD4⁺ T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol, 2020, 351: 104096.
3.	Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev, 2021, 20(4): 102792.
4.	Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis, 2019, 26(1): 8-15.
5.	Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol, 2020, 31(7): 1387-1397.
6.	Zou R, Chen F, Chen D, et al. Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center. Ren Fail, 2020, 42(1): 950-957.
7.	Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int, 2020, 98(1): 20-26.
8.	Rahim S, Dhrolia MF, Nasir K, et al. Clinical characteristics and outcomes of coronavirus disease 2019 infection of in-center hemodialysis patients: an experience of a dialysis center from Pakistan. Saudi J Kidney Dis Transpl, 2022, 33(1): 16-30.
9.	Yadla M, Vadakkeveetil AK, Cherian A, et al. Clinical features and outcomes of 84 COVID-positive hemodialysis patients in a resource poor setting from India. Saudi J Kidney Dis Transpl, 2021, 32(2): 504-509.
10.	David P, Dotan A, Mahroum N, et al. Immune thrombocytopenic purpura (ITP) triggered by COVID-19 infection and vaccination. Isr Med Assoc J, 2021, 23(6): 378-380.
11.	Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol, 2017, 177(1): 27-38.
12.	Ochani R, Asad A, Yasmin F, et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med, 2021, 29(1): 20-36.
13.	許瑩, 王亞萍, 林瑩, 等. 新型冠狀病毒感染合并重度免疫性血小板減少癥 1 例報告. 內科急危重癥雜志, 2021, 27(6): 523-525.

1. Tumaini Massaro J, Chen Y, Ke Z. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis. Platelets, 2019, 30(7): 828-835.
2. Kostic M, Zivkovic N, Cvetanovic A, et al. CD4⁺ T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol, 2020, 351: 104096.
3. Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev, 2021, 20(4): 102792.
4. Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis, 2019, 26(1): 8-15.
5. Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol, 2020, 31(7): 1387-1397.
6. Zou R, Chen F, Chen D, et al. Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center. Ren Fail, 2020, 42(1): 950-957.
7. Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int, 2020, 98(1): 20-26.
8. Rahim S, Dhrolia MF, Nasir K, et al. Clinical characteristics and outcomes of coronavirus disease 2019 infection of in-center hemodialysis patients: an experience of a dialysis center from Pakistan. Saudi J Kidney Dis Transpl, 2022, 33(1): 16-30.
9. Yadla M, Vadakkeveetil AK, Cherian A, et al. Clinical features and outcomes of 84 COVID-positive hemodialysis patients in a resource poor setting from India. Saudi J Kidney Dis Transpl, 2021, 32(2): 504-509.
10. David P, Dotan A, Mahroum N, et al. Immune thrombocytopenic purpura (ITP) triggered by COVID-19 infection and vaccination. Isr Med Assoc J, 2021, 23(6): 378-380.
11. Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol, 2017, 177(1): 27-38.
12. Ochani R, Asad A, Yasmin F, et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med, 2021, 29(1): 20-36.
13. 許瑩, 王亞萍, 林瑩, 等. 新型冠狀病毒感染合并重度免疫性血小板減少癥 1 例報告. 內科急危重癥雜志, 2021, 27(6): 523-525.

Previous Article
Recent advances in lipid metabolism of acute leukemia
Next Article
產前超聲表現為胎兒多囊性腎發育不良的Williams-Beuren 綜合征兩例

West China Medical Journal

維持性血液透析患者感染新型冠狀病毒后并發免疫性血小板減少一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content